234 related articles for article (PubMed ID: 35417991)
1. Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022.
Raju MK; Vivian Thangaraj JW; Selvavinayagam TS; Somasundaram A; Parthipan K; Sivadoss R; Sabarinathan R; Subramaniam S; A Rozario AG; Rani SD; Suganya E; Murhekar MV
Indian J Med Res; 2022 Jan; 155(1):165-170. PubMed ID: 35417991
[TBL] [Abstract][Full Text] [Related]
2. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
Wolter N; Jassat W; Walaza S; Welch R; Moultrie H; Groome M; Amoako DG; Everatt J; Bhiman JN; Scheepers C; Tebeila N; Chiwandire N; du Plessis M; Govender N; Ismail A; Glass A; Mlisana K; Stevens W; Treurnicht FK; Makatini Z; Hsiao NY; Parboosing R; Wadula J; Hussey H; Davies MA; Boulle A; von Gottberg A; Cohen C
Lancet; 2022 Jan; 399(10323):437-446. PubMed ID: 35065011
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
4. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
5. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Clinical Presentation and Vaccine Effectiveness Among Omicron and Non-omicron SARS Coronavirus-2 Patients.
Mohanty M; Mishra B; Singh AK; Mohapatra PR; Gupta K; Patro BK; Sahu DP; Kar P; Purushotham P; Saha S; Das S; Mamidi P; Panda S; Mandal MC; Bhuniya S
Cureus; 2022 Dec; 14(12):e32354. PubMed ID: 36628021
[TBL] [Abstract][Full Text] [Related]
8. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
BMJ; 2022 Mar; 376():e069761. PubMed ID: 35264324
[TBL] [Abstract][Full Text] [Related]
9. Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons.
Chaguza C; Coppi A; Earnest R; Ferguson D; Kerantzas N; Warner F; Young HP; Breban MI; Billig K; Koch RT; Pham K; Kalinich CC; Ott IM; Fauver JR; Hahn AM; Tikhonova IR; Castaldi C; De Kumar B; Pettker CM; Warren JL; Weinberger DM; Landry ML; Peaper DR; Schulz W; Vogels CBF; Grubaugh ND
Med; 2022 May; 3(5):325-334.e4. PubMed ID: 35399324
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological Characterization of Patients in the First Eight Weeks Following Detection of SARS-CoV-2 B.1.1.529 (omicron) Variant in Cuba.
Pérez-Santosa L; Kourí-Cardellá V; Tejero-Suárez Y; Macías-Roig LM; Pintos-Saavedra Y; Medero-Díaz D; Figueredo-Amador C; Naranjo-González C; Morales-Arredondo D; Tamayo-Pérez NE; Martínez-Montesino Y; López-Almaguer Y; de Armas-Fernández JR; Portal-Miranda JA; Guzmán-Tirado MG
MEDICC Rev; 2022 Oct; 24(3-4):18-23. PubMed ID: 36417330
[TBL] [Abstract][Full Text] [Related]
11. The spike gene target failure (SGTF) genomic signature is highly accurate for the identification of Alpha and Omicron SARS-CoV-2 variants.
McMillen T; Jani K; Robilotti EV; Kamboj M; Babady NE
Sci Rep; 2022 Nov; 12(1):18968. PubMed ID: 36347878
[TBL] [Abstract][Full Text] [Related]
12. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
[TBL] [Abstract][Full Text] [Related]
13. Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021.
Backer JA; Eggink D; Andeweg SP; Veldhuijzen IK; van Maarseveen N; Vermaas K; Vlaemynck B; Schepers R; van den Hof S; Reusken CB; Wallinga J
Euro Surveill; 2022 Feb; 27(6):. PubMed ID: 35144721
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods.
Shoji K; Tsuzuki S; Akiyama T; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Yamada M; Ozawa N; Yamaguchi K; Miyairi I; Ohmagari N
J Infect Chemother; 2023 Jan; 29(1):33-38. PubMed ID: 36103949
[TBL] [Abstract][Full Text] [Related]
15. Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.
Guerrero-Preston R; Rivera-Amill V; Caraballo K; Rodríguez-Torres S; Purcell-Wiltz A; García AA; Torres RS; Zamuner FT; Zanettini C; MacKay MJ; Baits R; Salgado D; Khullar G; Metti J; Baker T; Dudley J; Vale K; Pérez G; De Jesús L; Miranda Y; Ortiz D; García-Negrón A; Viera L; Ortiz A; Canabal JA; Romaguera J; Jiménez-Velázquez I; Marchionni L; Rodríguez-Orengo JF; Baez A; Mason CE; Sidransky D
Immun Inflamm Dis; 2022 Jun; 10(6):e634. PubMed ID: 35634961
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes.
Wong G; Rowlandson M; Sabanayagam D; Ginn AN; Kable K; Sciberras F; Au E; Draper J; Arnott A; Sintchenko V; Dwyer DE; Chen SCA; Kok J
Transplantation; 2022 Sep; 106(9):1860-1866. PubMed ID: 35675438
[TBL] [Abstract][Full Text] [Related]
17. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
18. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of clinical features and vaccination status in Omicron and non-Omicron infected patients during the third wave in Mumbai, India.
Takke A; Zarekar M; Muthuraman V; Ashar A; Patil K; Badhavkar A; Trivedi J; Khargekar N; Madkaikar M; Banerjee A
J Family Med Prim Care; 2022 Oct; 11(10):6135-6142. PubMed ID: 36618147
[TBL] [Abstract][Full Text] [Related]
20. Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021.
Smith-Jeffcoat SE; Pomeroy MA; Sleweon S; Sami S; Ricaldi JN; Gebru Y; Walker B; Brady S; Christenberry M; Bart S; Vostok J; Meyer S; Seys S; Markelz A; Ditto N; Newbern V; Thomas FJ; Thomas D; Cabredo E; Kellner S; Brown VR; Tate JE; Kirking HL
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):238-242. PubMed ID: 35176004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
